title: [Distribution of hepatitis B virus genotypes and its clinical significance in Guangxi].
abstract: OBJECTIVE
  To understand the distribution of hepatitis B virus genotype in Guangxi and its clinical significance.
  
  
  METHODS
  Nested polymerase chain reaction (nPCR) was used for amplification of HBV DNA in sera of asymptomatic carrier (ASC) of hepatitis B virus (HBV) and patients with different liver diseases from southern and northern Guangxi. Specimens from 161 subjects were positive for HBV DNA and HBV genotype was determined by using restriction fragment length polymorphism analysis, direct sequencing or cloning sequencing.
  
  
  RESULTS
  The prevalence of genotype A was 3.7% in all samples and that of genotype B, C and D was 21.7%, 72.7% and 1.2%, respectively. No other genotypes (such as genotype E, F, G, H) were found. The prevalence of genotype C showed an increasing trend in ASC, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC) group; in contrast, the prevalence of genotype B showed an opposite trend, although no statistically significant difference was observed, except between ASC and HCC (P=0.05). The HBeAg positive rate was higher, and the anti-HBe positive rate was lower in patients with chronic genotype C infection than in those with genotype B (P<0.05 for both). Liver function test (ALT) abnormality was more severe in genotype C group than in genotypes A and B groups having acute or chronic infection (P<0.01 for all comparisons). The prevalence of genotype C in southern Guangxi was higher than that in northern Guangxi. In contrast, the prevalence of genotype B in southern Guangxi was lower than that in northern Guangxi.
  
  
  CONCLUSIONS
  1. The predominant HBV genotypes in Guangxi were genotypes B and C. The major genotype in southern Guangxi was genotype C; while that in northern Guangxi was genotype B, which implied that the distribution of HBV genotype C was consistent with the incidence of HCC in Guangxi. 2. Genotype C maybe associated with development of severe liver diseases including HCC. 3. Genotype A,D and B+C were mostly found in acute, hepatitis and chronic hepatitis group.
authors.affiliation: Guangxi Institute of Occupational Health, Nanning, Guangxi 530021, China.
authors.forename: Xian-min
authors.initials: XM
authors.lastname: Ge
authors.forename: Dan-ya
authors.initials: DY
authors.lastname: Li
authors.forename: Zhong-liao
authors.initials: ZL
authors.lastname: Fang
authors.forename: Guo-yong
authors.initials: GY
authors.lastname: Huang
authors.forename: Shi-qiang
authors.initials: SQ
authors.lastname: Jiang
authors.forename: Hai-dong
authors.initials: HD
authors.lastname: Pan
authors.forename: Yan
authors.initials: Y
authors.lastname: Du
authors.forename: Chao-ying
authors.initials: CY
authors.lastname: Wang
authors.forename: Xin
authors.initials: X
authors.lastname: Ding
authors.forename: Mizokami
authors.initials: M
authors.lastname: Masashi
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000821:virology; D002353:Carrier State / Q000821:virology; D004279:DNA, Viral / Q000097:blood / Q000235:genetics*; D005260:Female; D005838:Genotype; D006513:Hepatitis B e Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000821:virology*; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000821:virology; D008297:Male; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length
chemical_list: D004279:DNA, Viral; D006513:Hepatitis B e Antigens